Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies

Autor: Vergote, I.B., Lund, B., Peen, U., Umajuridze, Z., Mau-Sorensen, M., Kranich, A., Van Nieuwenhuysen, E., Haslund, C., Nottrup, T., Han, S.N., Concin, N., Unger, T.J., Chai, Y., Au, N., Rashal, T., Joshi, A., Crochiere, M., Landesman, Y., Shah, J., Shacham, S., Kauffman, M., Mirza, M.R.
Zdroj: In Gynecologic Oncology February 2020 156(2):308-314
Databáze: ScienceDirect